HDAC-IN-39

Modify Date: 2024-01-08 09:07:30

HDAC-IN-39 Structure
HDAC-IN-39 structure
Common Name HDAC-IN-39
CAS Number 2414046-33-4 Molecular Weight 502.58
Density N/A Boiling Point N/A
Molecular Formula C27H26N4O4S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of HDAC-IN-39


HDAC-IN-39 (compound 16c) is a potent HDAC inhibitor, with IC50 values of 1.07 μM (HDAC1), 1.47 μM (HDAC2), and 2.27 μM (HDAC3), respectively. HDAC-IN-39 also significantly inhibits microtubule polymerization. HDAC-IN-39 induces cell cycle arrest at the G2/M phase. HDAC-IN-39 displays promising anticancer activity against resistant cancer cells[1].

 Names

Name HDAC-IN-39

 HDAC-IN-39 Biological Activity

Description HDAC-IN-39 (compound 16c) is a potent HDAC inhibitor, with IC50 values of 1.07 μM (HDAC1), 1.47 μM (HDAC2), and 2.27 μM (HDAC3), respectively. HDAC-IN-39 also significantly inhibits microtubule polymerization. HDAC-IN-39 induces cell cycle arrest at the G2/M phase. HDAC-IN-39 displays promising anticancer activity against resistant cancer cells[1].
Related Catalog
Target

HDAC1:1.07 μM (IC50)

HDAC2:1.47 μM (IC50)

HDAC3:2.27 μM (IC50)

HDAC8:>10 μM (IC50)

References

[1]. Wu WC, et al. Design, synthesis, and evaluation of N-phenyl-4-(2-phenylsulfonamido)-benzamides as microtubule-targeting agents in drug-resistant cancer cells, displaying HDAC inhibitory response. Eur J Med Chem. 2020 Apr 15;192:112158.

 Chemical & Physical Properties

Molecular Formula C27H26N4O4S
Molecular Weight 502.58
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.